Zydus, RK Pharma enters into an exclusive licensing and commercialisation agreement for a novel 505(b)(2) oncology product for USA market Read more
CDC’s vaccine advisory committee overhaul raises concerns for vaccine oversight: GlobalData Read more
China’s biopharma commands $30 billion in oncology licensing deals, triples US output in 2024 Read more